Gilead's lenacapavir reduced HIV infections by 96% in trial

A pharmacist holds a bottle of lenacapavir, the new injectable drug for HIV prevention. Nardus Engelbrecht | AP GileadPfizer's twice-yearly…

$1 billion in cost cuts and 10 planned product launches

Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Plexi Images | GHI | UCG | Universal Images Group | Getty Images…